X-linked Emery-Dreifuss muscular dystrophy is associated with a high risk of malignant ventricular arrhythmia

Abstract

Listen

Translate article

Abstract Background Emery-Dreifuss muscular dystrophy (EDMD) is caused by variants in EMD (X-linked) and LMNA (autosomal dominant). LMNA variants are known to cause end-stage heart failure (ESHF) and malignant ventricular arrhythmia (MVA) [1], but the risk of cardiac complications in EMD variant-carriers is unknown. Purpose To determine the incidence of MVA and ESHF in EMD variant-carriers. Methods Consecutively referred individuals carrying EMD variants were recruited from 12 cardiomyopathy units in Europe and the USA. The incidence of MVA and ESHF in male and female EMD variant-carriers was determined. Male EMD variant-carriers with a cardiac phenotype at baseline (EMDcardiac) were compared to consecutively recruited male LMNA variant-carriers with a cardiac phenotype (LMNAcardiac). Results Longitudinal follow-up data were available for 38 male and 21 female EMD variant-carriers (mean (SD) ages 33.4 (13.3) and 43.3 (16.8) years, respectively; Table 1). Nine (23.6%) males developed MVA and five (13.2%) developed ESHF during a median follow-up time of 65.0 [24.3, 109.5] months. No female EMD variant-carrier had MVA or ESHF, but nine (42.8%) developed a mild cardiac phenotype at a median [IQR] age of 58.6 [53.2, 60.4] years. Incidence rates for MVA were similar for EMDcardiac and LMNAcardiac (4.8 versus 6.6 per hundred person-years, respectively; log-rank test p = 0.49; Figure 1). Incidence rates for ESHF were 2.4 per hundred person-years for EMDcardiac and 5.9 per hundred person-years for LMNAcardiac (log-rank test p = 0.09; Figure 1). Conclusions Male EMD variant-carriers have a high risk of progressive heart failure and ventricular arrhythmias similar to that of male LMNA variant-carriers. These data suggest that early ICD implantation and heart failure drug therapy should be considered in male EMD variant-carriers with cardiac disease.Table 1Figure 1